...
首页> 外文期刊>形成外科 >CD10,CD99の免疫組織学的検討を行ったatypical fibroxanthomaの1例
【24h】

CD10,CD99の免疫組織学的検討を行ったatypical fibroxanthomaの1例

机译:一种非典型纤维体的案例,其进行了CD10,CD99的免疫组织学研究

获取原文
获取原文并翻译 | 示例
           

摘要

The patient was a 56-year-old man who had a 1cm nodule on his left cheek. The tumor was simply excised at the former hospital, but two months after that excision, recurrence resulted. Then, in our hospital, this lesion was removed on the surface of the muscle with surgical margin of about lcm and trilobed flap was used for wound closure. The pathological diagnosis was recurrent atypical fibroxanthoma. After the operation, we examined immunoreactivity to CD10 and CD99 for a specimen of the simple excision. For 10 months after our surgery, there was no recurrence or metastasis.Atypical fibroxanthoma occurs mostly on the head and neck of elderly people. It is characterized as following a benign clinical course despite its histological appearance.Histological differential diagnoses for atypical fibroxanthoma include malignant fibrous histiocytoma, squamous cell carcinoma, and malignant melanoma. Recently, immu no hi sto chemical markers CD10 and CD99 are thought to be useful in diagnosis.
机译:患者是一个56岁的男人,他的左脸颊上有1厘米。 肿瘤只是在前医院切除,但在切除后两个月后,重复发生。 然后,在我们院,将该病变除去肌肉的表面,具有关于LCM的手术边缘,并且Trilobed Plap用于伤口闭合。 病理诊断是复发的非典型纤维体。 在操作后,我们将对CD10和CD99的免疫反应检查为简单切除的标本。 在我们的手术后10个月,没有复发或转移。七种肌瘤大部分发生在老年人的头部和颈部。 它的特征在于良性临床课程,尽管其组织学外观。非典型纤维瘤的病理学鉴别诊断包括恶性纤维组织细胞瘤,鳞状细胞癌和恶性黑色素瘤。 最近,IMMU没有STO化学标记CD10和CD99被认为可用于诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号